Home - Products - Others - Other Targets - Gadolinium(III) chloride hexahydrate

Gadolinium(III) chloride hexahydrate

CAS No. 13450-84-5

Gadolinium(III) chloride hexahydrate( —— )

Catalog No. M35902 CAS No. 13450-84-5

Gadolinium(III) chloride hexahydrate is a contrast agent in magnetic resonance imaging and can be used in medicine, magnetic resonance imaging, liquid crystal displays and other fields.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
500MG 40 In Stock
1G 57 In Stock

Biological Information

  • Product Name
    Gadolinium(III) chloride hexahydrate
  • Note
    Research use only, not for human use.
  • Brief Description
    Gadolinium(III) chloride hexahydrate is a contrast agent in magnetic resonance imaging and can be used in medicine, magnetic resonance imaging, liquid crystal displays and other fields.
  • Description
    Gadolinium(III) chloride hexahydrate is a contrast agent in magnetic resonance imaging and can be used in medicine, magnetic resonance imaging, liquid crystal displays and other fields. Gadolinium(III) chloride hexahydrate can be used to synthesize complexes and nanomaterials.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Others
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    13450-84-5
  • Formula Weight
    371.7
  • Molecular Formula
    Cl3GdH12O6
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    Cl[Gd](Cl)Cl.O.O.O.O.O.O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • Benzoyl hydrazine

    Benzoyl hydrazine has a wide range of applications in life science related research.

  • DiO

    DiO (DiOC18(3)) is a fluorescent lipophilic tracer and can be widely used to label cells, organelles, liposomes, viruses, and lipoproteins.

  • Polymyxin B

    Polymyxin B, an antibiotic, combats Gram-negative infections through high-affinity binding to the bacterial wall's lipopolysaccharides (LPS), neutralizing endotoxin effects and inducing bacterial cell death by enhancing permeability.